Summary of Significant Accounting Policies - Schedule of Potential Additional Dilutive Securities (Details) |
3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2025
shares
|
Dec. 31, 2024
shares
|
Dec. 31, 2023
shares
|
Dec. 31, 2022
shares
|
|
Series A Convertible Preferred Shares | 3,269,998 | 3,269,998 | ||
Conversion rate | 0.2 | 0.00002 | 0.00002 | |
Common shares after conversion | 654,000 | 654,000 | 654,000 | |
Option shares | 88,510 | 109,584 | ||
Warrant [Member] | ||||
Warrant shares | 88,510 | |||
Series A Preferred Stock [Member] | ||||
Series A Convertible Preferred Shares | 3,269,998 | 3,269,998 | ||
Share-Based Payment Arrangement, Nonemployee [Member] | ||||
Option shares | 150,125 |
X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of common shares issuable upon conversion for each share of preferred stock to be converted. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|